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Abstract
Background: Fluorescent protein (FP)-based biosensors based on the principle of intramolecular Förster resonance
energy transfer (FRET) enable the visualization of a variety of biochemical events in living cells. The construction of
these biosensors requires the genetic insertion of a judiciously chosen molecular recognition element between
two distinct hues of FP. When the molecular recognition element interacts with the analyte of interest and
undergoes a conformational change, the ratiometric emission of the construct is altered due to a change in the
FRET efficiency. The sensitivity of such biosensors is proportional to the change in ratiometric emission, and so
there is a pressing need for methods to maximize the ratiometric change of existing biosensor constructs in order
to increase the breadth of their utility.
Results: To accelerate the development and optimization of improved FRET-based biosensors, we have developed
a method for function-based high-throughput screening of biosensor variants in colonies of Escherichia coli. We
have demonstrated this technology by undertaking the optimization of a biosensor for detection of methylation of
lysine 27 of histone H3 (H3K27). This effort involved the construction and screening of 3 distinct libraries: a domain
library that included several engineered binding domains isolated by phage-display; a lower-resolution linker library;
and a higher-resolution linker library.
Conclusion: Application of this library screening methodology led to the identification of an optimized H3K27-
trimethylation biosensor that exhibited an emission ratio change (66%) that was 2.3 × improved relative to that of
the initially constructed biosensor (29%).
Background
By providing researchers with a means of genetically
encoding fluorescence, fluorescent proteins (FPs) have
essentially turned mammalian cells into living test tubes
for performing many types of biochemical assays. One
of the most sophisticated applications of FPs is their use
in the construction of proteinaceous biosensors for a
variety of enzyme activities in live cells [1]. A biosensor
design strategy that has proven to be particularly robust
and versatile is the modulation of Förster resonance
energy transfer (FRET) efficiency between a blue shifted
donor FP and a red shifted acceptor FP [2]. The key to
creation of such biosensors is that a protein containing
both a donor and an acceptor FP undergoes an enzyme
activity-dependent conformational change such that the
distance and/or fluorophore dipole orientation between
the FPs is modified [3]. This change in distance or
orientation results in a change in FRET efficiency that
manifests itself as a change in emission ratio.
Although the designs principles of FRET-based bio-
sensors are relatively well-established [1], methods for
optimizing the signal-to-noise ratio of the FRET change
are not. The goal of any optimization effort is to maxi-
mize the ratio change between the initial and final states
of the biosensor by maximizing the change in distance
and/or fluorophore dipole orientation [3]. Although
some progress has been made in the computational pre-
diction of FRET changes [4], empirical screening
remains the most effective method of achieving substan-
tial improvements. Previous optimization efforts have
involved the tedious and systematic modification of the
linkers, topology, and domain identities [5-7]. In one of
the single most exhaustive efforts to optimize a FRET
based biosensor, 176 systematically varied linker
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combinations of a glutamate biosensor were constructed
and individually tested in vitro to identify the one with
the highest ratio change [7]. The position in ‘linker
space’ and the magnitude of ratio change did not follow
any predictable trend and only one of the 176 linker
combinations exhibited a substantial increase in ratio
change. Clearly, rapid and high-throughput means for
optimizing combinations of two or three linkers in
FRET-based biosensors could accelerate the develop-
ment of improved tools for both basic biochemical and
applied pharmaceutical research.
Inspired by the fact that fluorescence screening in bac-
terial colonies has been the technology of choice for the
directed evolution of improved FPs, we sought to extend
this methodology to the screening of biosensors. How-
ever, unlike individual FPs that have a static and
unchanging fluorescence, biosensors have a dynamic
fluorescence emission that must be imaged in both its
initial baseline state and its final stimulated state.
Accordingly, the primary challenge of screening biosen-
sors in bacterial colonies is how to induce the biochem-
ical change (e.g., onset of an enzyme activity or a change
in small molecule concentration), that the biosensor is
designed to sense. To address this challenge we have
developed a screening system in which the functional
response of a FRET-based biosensor for a post-transla-
tional modification can be artificially induced in live
bacterial colonies. We note that an alternative approach
to addressing this challenge is to optimize a FRET-based
biosensor in mammalian cells. In recent work, Piljić et
al. have used this alternative approach to optimize the
FRET response of biosensors for detection of the activa-
tion of two calcium/calmodulin-dependent kinases [8].
The advantage of this approach is that the sensor is
optimized for use in the same context in which it will
ultimately be applied. A disadvantage is that the
throughput of the screening approach is substantially
less than what can be achieved using bacterial colonies.
As a model system for demonstrating the utility of
screening in bacterial colonies, we have undertaken the
optimization of a biosensor for enzymatic trimethylation
of lysine 27 of histone H3 (H3K27) (Figure 1). A pre-
viously reported biosensor of this enzyme activity [9],
which was rationally designed based on x-ray crystallo-
graphic information [10,11] and not empirically opti-
mized, had a ratio change of 28%. As a similar biosensor
for methylation of lysine 9 of histone H3 (H3K9) had a
ratio change of 60% [9], it seemed reasonable that
further improvements of a H3K27-trimethylation bio-
sensor (hereafter abbreviated as H3K27-MetBio) could
be achieved with linker optimization. Another important
consideration was the availability of the Paramecium
bursaria chlorella virus SET domain protein (vSET) that
catalyzes H3K27-trimethylation and can be produced in
soluble and active form in E. coli [12,13].
Results and discussion
Design and optimization of a colony-based screening
system
To achieve the inducible post-translational modification
of a H3K27-MetBio in E. coli, we designed a dual
expression plasmid (designated pUADE) that expresses
the biosensor construct under control of the tac promo-
ter (Ptac) [14] and vSET under control of the araBAD
promoter (PBAD) [15] (Figure 2A). We reasoned that a
single-plasmid based approach would simplify the
Figure 1 Representation of the H3K27-trimethylation biosensor (H3K27-MetBio). The biosensor is a four-part genetic chimera composed of
the FRET donor mTFP1 [18], a domain that binds to methylated lysine residues, residues 20 to 33 of histone H3 (GenBank: CAA40407), and the
FRET acceptor mCitrine [37]. The first (L1), second (L2), and third (L3) linkers are represented with dotted lines. L1 starts immediately after residue
225 of mTFP1 and ends immediately before residue 1 of the chromodomain. L2 starts immediately after the last residue of the chromodomain
and ends immediately before residue 21 of the histone H3-derived substrate. L3 starts immediately after the last residue of the substrate and
ends immediately before residue 6 of mCitrine. This biosensor design has been previously reported [9].
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experimental procedures by eliminating the need for
multiple transformations and more than one resistance
marker. The PBAD promoter was chosen because it has
been reported to provide tight regulation of gene
expression [16] and would allow us to use L-arabinose
to selectively “turn on” vSET expression in colonies of
E. coli that are also expressing the biosensor (Figure 2B).
To determine the level of induction that we could
achieve for vSET under the PBAD promoter, in the con-
text of E. coli colonies grown under conditions that
would also induce Ptac, we used both Western blot ana-
lysis and fluorescence imaging of bacterial colonies. As
shown in Figure 3A-D, Western blot analysis with an
anti-His-tag antibody was used to qualitatively deter-
mine the relative abundance of vSET (in pBAD/His B)
in E. coli grown on media containing various concentra-
tions of D-glucose, IPTG, and L-arabinose. As expected,
vSET expression was very strong under the inducing
conditions (Figure 3A; with L-arabinose), but was not
detectable under the repressive conditions (Figure 3B;
with D-glucose). Spraying of the colonies grown under
the repressive conditions with a concentrated solution
of L-arabinose (1 M) resulted in a substantial increase
in the amount of vSET over a time period of 3 hours
(Figure 3C), though the protein did not reach the same
abundance as in the colonies grown in the presence of
L-arabinose (compare to Figure 3A). If D-glucose was
not included in the growth media, the PBAD promoter
was not fully repressed as indicated by the detection of
vSET protein (Figure 3D). We noted that colonies
Figure 2 A dual expression system for induced post-translational modification of a genetically encoded biosensor. (A) Plasmid map of
pUADE. Ptac is an IPTG-inducible promoter and PBAD is an L-arabinose-inducible promoter. (B) Schematic representation of protein expression
from pUADE in E. coli in the presence of both IPTG and L-arabinose. In the absence of L-arabinose, the PBAD promoter is inactive and no vSET is
produced.
Figure 3 Optimization of expression conditions. Western blots showing expression of vSET for colonies of E. coli grown in the presence or
absence of inducer. For each condition, 20 μg of total protein was loaded in the left lane and 2 μg was loaded in the right lane. (A) Media
containing IPTG (1 mM) and L-arabinose (13 mM). (B) Media containing IPTG (1 mM) and D-glucose (11 mM). (C) Media conditions identical to
(B), 3 h after being sprayed with a concentrated solution of L-arabinose. (D) Media containing IPTG (1 mM).
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grown on media that contains L-arabinose and IPTG,
but no D-glucose, tended to be relatively small, suggest-
ing an increased metabolic burden on the E. coli [17].
Having confirmed that vSET expression could be
“turned on” in colonies by treating with L-arabinose, we
next tested whether we could induce a change in the
FRET emission signal of a H3K27-MetBio expressed in
colonies of E. coli. Accordingly, we constructed the
pUADE plasmid with vSET under the PBAD promoter
and a first generation H3K27-MetBio (H3K27-MetBio1)
under the Ptac promoter. In contrast to the previously
reported H3K27 biosensor [9] which incorporated the
CFP-YFP FRET pair and the Polycomb chromodomain
[10,11], H3K27-MetBio1 incorporated the mTFP1-mCi-
trine FRET pair [18] and the Cbx7 chromodomain [19]
(Figure 1). Cbx7 has high homology with Polycomb and
exhibits a strong preference for binding to trimethylated
H3K27 over the di-, mono-, and unmethylated forms
[19]. The choice of the Cbx7 chromodomain was later
revealed to be fortuitous since this binding domain pro-
duced the largest FRET ratio change of all domains
tested. CFP was substituted with mTFP1 due to the
improved brightness and photostability of the latter pro-
tein [18]. Following our convention for linker length
description (refer to Figure 1 legend), L1, L2, and L3 of
H3K27-MetBio1 consisted of 8, 22, and 6 amino acids
respectively. The sequences of L1 and L3 corresponded
to the normal C- and N-terminal sequences of the
respective FPs in addition to the amino acids encoded
by the codons of the restriction sites (in case of L1). L2
corresponded to a 18-residue unstructured linker [20]
flanked by the two amino acids at each end that are
encoded by the restriction sites. The complete sequence
of H3K27-MetBio1 and other key variants is provided in
Figure 4A.
In vitro characterization of H3K27-MetBio1 revealed
that this construct exhibited a 29% change in emission
ratio change upon treatment with vSET in the presence
of S-adenosyl methionine (SAM) (Figure 4B). To deter-
mine if methylation of H3K27-MetBio1 was also occur-
ring in E. coli under conditions where vSET was being
expressed, we transformed cells with the pUADE-(vSET;
H3K27-MetBio1) plasmid and cultured colonies (100s
per plate) on media supplemented with 1 mM IPTG
plus various combinations of L-arabinose and D-glucose.
After allowing colonies to grow overnight at 37°C, plates
were imaged using a fluorescence imaging system
equipped with bandpass filters that allowed us to
acquire fluorescence images of the mTFP1 donor (426-
446 nm excitation and 460-500 nm emission) and the
acceptor fluorescence due to FRET (426-446 nm excita-
tion and 520-550 nm emission) [21]. Processing of the
digital images provided the average acceptor to donor (i.
e., FRET/mTFP1) ratios for the colonies. As shown in
Figure 4C, the FRET/mTFP1 ratios for colonies grown
in the presence of L-arabinose and D-glucose were sub-
stantially higher than those grown in the presence of D-
glucose alone. This result provided strong support for
Figure 4 Structure and characterization of H3K27-MetBio1. (A) Sequence alignment of H3K27-MetBio1, H3K27-MetBio2, and H3K27-MetBio3.
Underlined residues in the H3K27-MetBio2 and H3K27-MetBio3 sequences denote amino acids encoded by restriction sites for Kpn1 (GT), Sal1
(GST), and Eag1 (TAG). (B) Emission spectra of the H3K27-MetBio1 protein in both the methylated and unmethylated state, normalized to
acceptor intensity. (C) Image-based emission ratios for H3K27-MetBio1 in colonies of E. coli that were grown on different plate compositions. All
plates contained 1 mM IPTG.
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the conclusion that H3K27-MetBio1 could be methy-
lated by recombinant vSET in the context of E. coli
colonies. For all future experiments we used 20 mM D-
glucose as our repressing condition (hereafter, ‘glucose’
plates) and 10 mM L-arabinose as our inducing condi-
tion (’arabinose’ plates). Both the glucose and arabinose
plates contained 1 mM IPTG to induce the production
of H3K27-MetBio. Unlike the very slow growing colo-
nies on plates containing only L-arabinose and IPTG,
colonies grown on media with both L-arabinose and D-
glucose grew at a rate that was comparable to colonies
grown on media containing only D-glucose. Presumably,
adding D-glucose decreased vSET expression to a level
that is less metabolically burdensome.
Library screening identifies biosensors with increased
FRET changes
Having established that it was possible to methylate
H3K27-MetBio1 in the context of bacterial colonies and
then image the resulting change emission ratio for hun-
dreds of individual colonies on a single plate, we next
explored various methods of using this technology for
library screening. Our goal was to identify the most
robust and reliable procedure by which the emission
ratio of a single clone could be determined under both
inducing and repressing conditions for vSET expression.
Seemingly, the ideal solution would be to image colonies
on repressive media, spray with sufficient L-arabinose to
induce vSET expression, and then image the same plate
again. This approach proved challenging to implement
due to the difficulty in getting a uniform application of
spraying solution. Replica plating onto both inducing
and repressing media seemed to offer an alternative
solution, but ended up presenting new challenges that
were ultimately insurmountable for us. Specifically, hav-
ing missing colonies on one replicate was sufficient to
make the digital processing steps effectively intractable,
as the correlation between identical clones on the two
different plates could not be automatically determined
in software. We ultimately settled on the very robust,
but more labor intensive, approach of manual plate
replication by spotting of single colonies in two sets of
ordered arrays. This approach achieved the goal of hav-
ing identical clones cultured under both repressing and
inducing conditions, and also greatly simplified the later
digital image processing steps. A schematic representa-
tion of this library screening protocol is provided in Fig-
ure 5. Digital image processing using custom macros
was used to extract the intensity for each colony on
both replicate plates in both the donor and acceptor
emission channels. Using the equation shown in Figure
5, the change in emission ratio for the transition from
unmethylated to methylated biosensor (ΔR/R%) was cal-
culated for each colony. Colonies exhibiting the highest
ΔR/R% values were picked and cultured in order to pro-
vide plasmid DNA for sequencing.
Our overall strategy for optimizing the H3K27-MetBio
involved the construction and subsequent screening of 3
iterative libraries; a domain library (lib1), a low resolu-
tion linker library (lib2), and a higher resolution linker
library (lib3). Lib1 was kept quite small and consisted of
just 7 distinct H3K27-MetBio1-derived variants, each of
which had identical linkers but different binding
domains. Four of the 7 binding domains were wild-type
domains: amino acids 56-118 of CDY1 (chromodomain),
accession AAD22735; amino acids 77-128 of C20orf140
(tudor domain), accession NP_057520; amino acids 890-
1011 of JMJD2A (double tudor domain), accession
NP_055478; and amino acids 36-97 of Cbx7 (chromodo-
main), accession EDL04620 [19,22]. The other 3
domains were variants of the wild-type domains that
had been engineered for altered binding specificities
towards trimethylated lysines: Cbx7 chromodomain
A91K; JMJD2A double tudor domain D945K; and
JMJD2A double tudor domain D945R. These engineered
variants had been discovered by a phage display effort
aimed at improving the binding specificity and/or affi-
nity of these domains. As the gains in specificity and
affinity were modest despite a substantial investment of
effort, we did not further pursue the original goal. How-
ever, we did decide to include the best of the engineered
variants in lib1 in the expectation that they could poten-
tially alter the FRET response of the biosensor. Full
details of the phage display effort is provided in Addi-
tional File 1.
For library screening, E. coli was transformed with the
lib1 plasmid library and plated on regular LB/agar
media. Individual colonies were picked at random and
spotted onto both the inducing and repressing media at
Figure 5 Library screening methodology. To screen libraries of
biosensor variants for clones exhibiting improved ratio changes, an
image-based method was used to determine FRET ratio changes in
individual colonies of E. coli previously transformed with the
plasmid library.
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the same position within a regular grid. Approximately
24 h later, the colony grids were imaged as described
above and colonies that exhibited the highest ΔR/R%
values (a FRET increase) were picked, cultured, and
their plasmid DNA isolated. DNA sequencing revealed
that 9 contained Cbx7 and 1 contained Cbx7 A91K.
The Cbx7 domain was not identified in clones that
exhibited the lowest ΔR/R% values. This strong consen-
sus clearly demonstrated that this screening approach
could be used to identify H3K27-MetBio variants from
colony-based libraries.
Having identified the preferred binding domain for
H3K27-MetBio, our next goal was to find the combina-
tion of linkers that provided the optimal FRET ratio
change. Accordingly, we constructed a second library
(lib2) that was designed to contain 392 members that
each had one of seven different lengths of L1 (ranging
from 0 to 14 residues), eight different lengths of L2
(ranging from 0 to 20 residues), and seven different
lengths for L3 (ranging from 0 to 14 residues). All lin-
kers were composed primarily of glycine, alanine and
serine, likely rendering them unstructured and highly
flexible. By design, lib2 was relatively ‘coarse’ as our pri-
mary goal was to reveal the general trends in preferred
linker length, such that we could eventually design a
more refined second linker library.
To identify the best linker length combinations from
lib2, six pairs of ‘glucose’ and ‘arabinose’ plates, each
with 45 re-spotted colonies, were screened as shown in
Figure 5. The average ratio change for all colonies was
determined to be 14% with a standard deviation of 4%
(Figure 6A). The three colonies which showed the high-
est FRET ratio changes; one which showed the lowest;
and other 9 clones which showed average values were
picked, cultured, and the H3K27-MetBio genes were
sequenced. Sequencing results revealed that colonies
which showed the highest ratio changes had L1 and L3
linker lengths of 0, and L2 linker lengths of 10, 14, or
20 (Figure 6B). The variant with L2 = 20 residues was
designated as H3K27-MetBio2 (Figure 4A and 7A).
The results of lib2 screening suggested to us that
the combination of a short L1, a long L2, and a short
L3 linker would provide H3K27-MetBio variants with
the highest FRET changes. This observed linker length
pattern can be rationalized on the basis of the solu-
tion NMR structure of the Cbx7 chromodomain in
complex with a trimethylated H3K27-containing pep-
tide [23]. The structure reveals that the N-terminus of
Cbx7 (to which mTFP1 is fused in H3K27-MetBio) is
in close proximity to the C-terminus of the H3K27
peptide (to which mCitrine is fused in H3K27-Met-
Bio). Accordingly, we expect that shorter L1 and L3
linkers, located at the N-terminus of Cbx7 and the C-
terminus of the substrate peptide, respectively, could
serve to hold the mTFP1-mCitrine FRET pair in clo-
ser proximity in the compacted (i.e., trimethylated)
state of the biosensor and provide higher FRET effi-
ciency than longer linkers would. In the extended (i.e.,
unmethylated) state of the biosensor, a longer L2 lin-
ker could serve to increase the overall distance
between the FPs and provide a lower FRET efficiency
than shorter linkers would. So overall, the observed
linker combination is a reasonable solution to provid-
ing the maximal change in FRET efficiency upon
methylation of H3K27-MetBio.
Guided by the results of the lib2 library screening, we
attempted to further refine the H3K27-MetBio linkers
by construction and screening of a second linker library
designated lib3. The lib3 library consisted of 640 var-
iants arising from the possible combination of ten L1
linkers (ranging from -4 to +5 residues), eight L2 linkers
(ranging from 6 to 30 residues), and eight L3 linkers
(ranging from -3 to +4 residues). Negative linkers indi-
cate truncations relative to either Gly225 of mTFP1 in
the case of L1 or relative to Glu6 of mCitrine in the
case of L3.
For screening of lib3, twelve pairs of ‘glucose’ and ‘ara-
binose’ plates were prepared, and the FRET ratio
changes of the colonies were calculated. The average
ratio change was found to be 38% with a standard devia-
tion of 16% (Figure 6C). Nine clones exhibiting high
ratio changes (> 70%), and twenty-two with average-to-
low ratio changes (< 70%) were picked for clonal expan-
sion and further characterization. Sequencing results
revealed that the L1 linker length in the high ratio
change variants ranged from -4 to +3, indicating that
there was no strong preference for any particular linker
length within this range (Figure 6D). In contrast, 7 of 9
high ratio change variants had an L3 of -2, indicating
that there is a much stronger dependence on this parti-
cular linker for achieving high ratio change. Similarly, 8
of the 9 clones with the highest ratio changes had L2 of
14 residues or longer. The variant with L1 = -2, L2 =
20, and L3 = -2 residues was designated as H3K27-Met-
Bio3 (Figure 4A and 7B).
The best two variants identified from lib2 and lib3,
H3K27-MetBio2 and H3K27-MetBio3, respectively, were
purified in their unmodified states and a portion of the
protein was subjected to an in vitro methylation assay.
Fluorescence emission scans were acquired using an
excitation wavelength of 420 nm (Figure 7AB) and ΔR/
R% was calculated for each biosensor. H3K27-MetBio2
demonstrated only a modest improvement in signal
change (37%) relative to the H3K27-MetBio1 (29%).
However, H3K27-MetBio3 exhibited a substantially
improved ΔR/R% of 66%, which is 2.3 × higher than
H3K27-MetBio1. All 3 sensors were methylated by vSET
at similar rates (Figure 7C).
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Imaging of chromatin-targeted H3K27-MetBio3
To investigate whether H3K27-MetBio3 could potentially
be used to report on H3K27 trimethylation in the context
of chromatin in living cells, we constructed a mammalian
expression vector encoding a fusion of a histone 2B (H2B)
and H3K27-MetBio3. Mouse embryonic fibroblast 3T3
cells transfected with this expression vector were viable
and observed to proceed through mitosis. Ratiometric
imaging of transfected cells revealed a speckle-like pattern
of high FRET regions within the interphase chromatin
(Figure 8) that is qualitatively similar to the pattern
reported for immunofluorescence imaging with anti-
H3K27 antibodies [24,25]. Further validation, potentially
including immunostaining of transfected cells followed by
imaging of colocalization with an antibody specific for
trimethylated H3K27, will be required to confirm that the
regions of high FRET do correspond with regions of high
H3K27 trimethylation. One confounding factor could be
local differences in H2B abundance that cause increased
or decreased amounts of intermolecular FRET.
Prospects for the dual expression library screening
strategy
With the successful identification of linker combinations
that provide improved ratio changes, we have demon-
strated that this dual expression library screening strat-
egy, in its current form, is of practical utility for
optimizing FRET-based biosensors designed to respond
to post-translational modification. We expect that this
system could be used to optimize a wide variety of
Figure 6 Results of linker library screening. (A) Histogram of FRET ratio changes of all colonies screened from lib2. The average FRET change
in colonies was 14% with a standard deviation of 4%. (B) Linker combinations identified during screening of lib2. The horizontal and the vertical
axes represent the number of amino acids constituting the first linker (L1) and the third linker (L3), respectively. The inputs for the second linker
(L2) are sequences of 0, 2, 4, 6, 8, 10, 14, and 20 residues in length. Identified L1 and L3 combinations are indicated on the grid by coloured
circles the size of which represents the number of sequenced clones with a given combination of L1 and L3, while the number of amino acids
constituting L2 of these clones is indicated by the numerical values assigned to the circles. Linker combinations exhibiting the highest FRET ratio
changes (> 20%) are represented by the green circle; orange circles represent clones with average-to-low ratio changes (< 20%); and grey circles
represent clones picked at random. (C) Data histogram of FRET ratio changes of colonies screened from lib3. The average FRET change in
colonies was 38% with a standard deviation of 16%. (D) Linker combinations identified during screening of lib3. Input for L2 are linkers of 6, 8,
10, 14, 15, 20, 25, or 30 residues in length. Linker combinations exhibiting high FRET ratio changes (> 70%) are represented with green circles
and those showing average-to-low ratio changes (< 70%) are represented by orange circles.
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biosensors for post-translation modification, provided
that the a constitutively active enzyme with the activity
of interest can be expressed in its functional form in E.
coli. However, the current implementation of the
screening system does have some drawbacks that will
hopefully be addressed in future versions. One drawback
of the current implementation is that, while the colony-
based screen did allow us to identify a population of the
best variants from a large library, it was not sufficient
for identifying the single best variant. Accordingly, a
secondary in vitro test was required for identification of
the variants with the highest FRET changes. A second
drawback was our reliance on manual spotting for the
replication of bacterial colonies, which severely limited
the throughput of the assay and increased the likelihood
of human error. An improved method for library screen-
ing would involve the on-plate induction of enzyme
expression. With this approach, images of the same
plate, before and after enzyme induction, could be
acquired and processed to identify the colonies with the
largest changes in emission ratio. Our own efforts to
achieve on-plate induction using the PBAD promoter and
application of L-arabinose by spraying did not provide
satisfactory results due to the heterogeneity of the appli-
cation. We expect that this limitation could be over-
come through the use of a promoter that could be
induced at the same level across the whole plate. One
potential solution is to use a cold-inducible promoter
[26], which could presumably be induced at the same
level in all colonies by simply changing the incubation
conditions of the plate. However, it is unclear whether
an alternate promoter could provide an equivalent level
of repression to PBAD in the uninduced state.
With improvements in this library screening strategy,
it should be possible to substantially increase the screen-
ing throughput. In the current implementation, we were
limited to screening hundreds of variants and thus our
screen is not exhaustive and has not necessarily yielded
the optimal linker combination. In addition, we only
investigated the effect of linker length on ratio change
and did not attempt to adjust linker composition. We
strongly suspect that further improvements in ratio
change could be achieved by screening of larger number
of variants and exploring both altered linker lengths and
compositions [27,28]. We also suspect that biosensors
with further improved ratio changes could be identified
by altering the orientation of the donor and acceptor
FPs by employing circularly permuted variants [29] or
using ‘sticky’ FP variants [30].
Figure 7 Characterization of the optimized biosensor. (A-B) Emission scans of H3K27-MetBio2 (A) and H3K27-MetBio3 (B) after treatment with
vSET in the presence or absence of SAM, normalized to acceptor intensity. (C) Time course of FRET ratio changes for H3K27-MetBio variants
treated with vSET and SAM and calculated using the ratio of fluorescence intensities at 526 nm and 494 nm.
Figure 8 Expression of H3K27-MetBio3 in mammalian cells. (A
and C) Representative ratiometric images of 3T3 cells expressing
H3K27-MetBio3 as a fusion with histone 2B. (B and D) DIC
transmitted light images of the same fields of view shown in A and
C, respectively. Scale bar is 10 microns.
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Conclusion
We have developed a method for high-throughput
screening of biosensor libraries with many hundreds of
different linker combinations. This approach should be
applicable to the optimization of any genetically
encoded biosensor for post-translational modification,
provided the gene encoding the enzyme activity of inter-
ested can be functionally expressed in E. coli. We have
demonstrated this technology by undertaking the opti-
mization of a biosensor for detection of methylation of
H3K27. Furthermore, we have shown that mammalian
cells expressing this biosensor as a histone fusion are
viable. Accordingly, we anticipate that H3K27-MetBio3
may facilitate future efforts to spatially resolve H3K27-
trimethylation patterns in living cells. Furthermore,
when compared to existing in vitro assays for histone
methyltransferase activity [31-33], this homogenous bio-
sensor-based assay is notable for requiring the least
number of reagents and liquid handling steps. Accord-
ingly, H3K27-MetBio3 may be particularly useful in
automated high-throughput screening efforts aimed at
the identification of H3K27 methyltransferase inhibitors
that could serve as chemical probes [34] or as leads for
the development of new cancer therapies [35].
Methods
General methods and materials
All primers and polynucleotides were purchased from
Integrated DNA Technologies and their sequences are
provided in Table S1, Additional file 2. Polymerase
chain reaction (PCR) was performed using either Taq
DNA polymerase (Invitrogen) or Pfu DNA polymerase
(Fermentas) according to the provided manufacturers’
protocols. Restriction endonucleases were purchased
from New England Biolabs and used in the buffers
recommended by the manufacturer. For routine analyti-
cal DNA digestion, FastDigest® restriction endonu-
cleases (Fermentas) were used. QIAquick Gel-Extraction
kit (Qiagen) was used for DNA purification following
agarose gel electrophoresis. DNA ligation was carried
out using T4 DNA ligase (Invitrogen). E. coli strain
ElectroMAX DH10B™ (Invitrogen) was used for routine
plasmid propagation, library construction and screening,
and recombinant protein production. Plasmid DNA for
both bacterial transformation and mammalian cell trans-
fection was isolated and purified using Fermentas Gene-
JET™-plasmid miniprep kit following the
manufacturer’s protocol. DNA sequencing reactions
were performed using either DYEnamic™ ET (Amer-
sham) or BigDye® (Applied Biosciences) terminator
cycle sequencing kits.
Bicinchoninic acid (BCA) protein assay (Pierce) was
routinely used to measure protein concentration follow-
ing the manufacturer’s microplate format procedure in
96-well plates (Corning) which were read on a Safire2
microplate reader (Tecan). To determine the concentra-
tion of chimeric proteins that contained mTFP1 [18],
absorbance at 462 nm was recorded on DU-800 spectro-
photometer (Beckman-Coulter) and concentration was
calculated using Beer-Lambert’s law. To assess the pur-
ity of recombinant proteins, Glycine-SDS-PAGE or Tri-
cine-SDS-PAGE - the choice of which was based on the
estimated molecular weight of the protein of interest -
was performed using 2 μg protein/lane [36] and PageRu-
ler™ prestained protein ladder (Fermentas). Unless
otherwise indicated, all chemicals and reagents were
purchased from Fisher Scientific. All culture media con-
tained ampicillin at a final concentrations of 0.04%.
Construction of the first generation biosensor H3K27-
MetBio1 and lib1
The gene encoding mTFP1 was used as the initial tem-
plate for three rounds of successive PCRs using the pri-
mers combinations: ‘Trugon1 Forward1 (Seq)’ and
‘Trugon1 Backward1 (Compl)’; ‘Trugon2 Forward2
(Seq)’ and ‘Trugon2 Backward2 (Compl)’; and ‘Trugon3
Forward3 (Seq)’ and ‘Trugon3 Backward3 (Compl).’ The
amplified product was digested with XhoI and EcoRI
and ligated into pBAD/His B plasmid that was digested
with the same enzymes. The resulting plasmid (referred
to as ‘Trugon-TFP’) had the five unique restriction sites
XhoI, XbaI, AvrII, PstI and BclI upstream of mTFP1
sequence; and BglII, EcoRI and HindIII downstream of
it. A separate PCR was performed to amplify mTFP1
with ‘TFP-XhoI-FD-SEQ’ and ‘TFP-XbaI-BK-CPL’ pri-
mers. The PCR-product was digested with XhoI and
XbaI enzymes and ligated into pBAD/His B based ‘Tru-
gon-TFP’ that was digested with the same restriction
enzymes. The resulting plasmid was digested with XbaI
and PstI for use in a subsequent ligation reaction.
The potential binding domains were each subcloned
into a pBAD/His B-derived plasmid that had the follow-
ing nucleotide scheme: AvrII-protein domain-218 linker-
XbaI-PstI. The ‘218 linker’ is a previously reported
sequence with good proteolytic stability [20]. Plasmids
containing these protein domains were each digested
with AvrII and PstI and the obtained inserts were
ligated with the previously mentioned XbaI and PstI
digested plasmid. The plasmid products were digested
with XbaI and HindIII enzymes and used in subsequent
ligation reactions. A nucleotide sequence encoding the
histone-derived substrate sequence were added to the 5’
end of mCitrine through two rounds of successive with
the primers: ‘1-XbaI-H3K27-SEQ’ and ‘YFP-BK-CPL’;
and ‘2-XbaI-H3K27-SEQ’ and ‘2-YF-BK-CPL.’ The
obtained products were digested with XbaI and HindIII
enzymes and ligated with the previously mentioned
XbaI and HindIII digested plasmid. This procedure
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produced plasmids encoding the 7 distinct potential bio-
sensor constructs.
Construction of the dual expression plasmid (pUADE)
To construct pUADE, the two primers ‘pGEX-For-TAC
(Seq)’ and ‘pGEX-Back-TAC (Comp)’ were used to
amplify a 264 bp fragment that contained Ptac from
pGEX-6P-1 plasmid (GE life sciences) and to introduce
BamHI and NcoI sites at that 5’ and 3’ ends, respec-
tively, of the amplification product. The obtained DNA
fragment was digested with BamHI and NcoI and was
ligated into pET22b plasmid (Novagen) that had been
digested with BglII and NcoI. Next, ‘Forward-BAD-
transfer’ and ‘Backward-BAD-transfer’ were used to
amplify the section of pBAD/His B extending from
nucleotide 333 to 765 (original plasmid numbering) and
to introduce PciI and BglII sites at the 5’ and 3’ ends
respectively. The obtained DNA was digested with PciI
and BglII and was ligated with the NcoI and BamHI
digested pET22b plasmid from the previous step. The
resulting plasmid was used as a template for a PCR
using the primers ‘POLY-Prmr1(pet)-Frwd’ and ‘POLY-
Prmr1(pet)-Backwrd’ to amplify the part of the plasmid
that encoded the LacI, the modified promoter and its
downstream multiple cloning site (MCS) and transcrip-
tion terminator. Digestion of the resulting DNA frag-
ment with PmlI provides the fragment designated as
‘POLY-Prmr1(pet)’.
A dsDNA fragment with 5’ and 3’ overhangs compati-
ble for ligation with XhoI and HindIII digested DNA
respectively was obtained by slowly cooling a buffered
solution of ‘MCS-SEQUENCE’ and ‘MCS-COMPLE-
MENTARY’ polynucleotides, at a concentration of 0.5
mM each, from 95°C to room temperature (RT) at a
rate of -1°C every 3 min. The obtained dsDNA was
ligated with pBAD/His B plasmid (Invitrogen) that had
been digested with XhoI and HindIII. This modified
pBAD plasmid was then digested with EcoRI and BglII
and ligated with the a similarly digested DNA fragment
created by PCR amplification of the vSET genes using
‘vSET-EcoRI-Frwd (seq)’ and ‘vSET-BglII-Bckd (Compl).’
The resulting plasmid, named ‘New MCS-pBAD,’ was
digested with BsaAI and ligated with the ‘POLY-Prmr1
(pet)’ fragment described above. This procedure pro-
vided the pUADE plasmid that had the vSET gene
inserted in an MCS under PBAD and a second MCS
under Ptac. pBAD/His B vectors containing the afore-
mentioned seven H3K27 methylation biosensors were
pooled together in equimolar amounts and subsequently
digested with XhoI and HindIII restriction enzymes.
DNA electrophoresis followed by gel extraction were
performed to purify the nucleotide inserts encoding the
biosensors which were subsequently ligated into XhoI-
HindIII restricted pUADE.
Construction of lib2 and lib3 linker libraries
To facilitate cloning of linker libraries, we incorporated
new restriction sites between the constituting parts of
the H3K27-MetBio to have the following scheme: XhoI-
mTFP1-KpnI-Cbx7-SalI-H3K27-EagI-mCitrine-HindIII.
To introduce the new restriction sites (italicized) in the
MCS downstream of PTac in pUADE, a stepwise assem-
bly of an initial construct with these new sites was per-
formed followed by its introduction in pUADE. Briefly,
double stranded DNA encoding the H3K27 substrate
was obtained by slowly cooling a buffered solution that
contained both coding polynucleotide strand ‘SalI(RF2)-
H3K27-Sense’ and its reverse compliment ‘EagI(RF3)-
H3K27-Antisense’ (at 0.5 μM each) from 95°C to 10°C
at temperature drop rate of -1°C every 3 min. The pro-
duct was purified using QIAquick Nucleotide Removal
Kit after which it was digested with SalI and re-purified.
The obtained product was ligated with SalI digested
Cbx7 that had been previously amplified using ‘FrWd-
KpnI(RF1)-Cbx7’ and ‘0-BkWd-SalI(RF2)-Cbx7’ primers.
After four hours of ligation, an aliquot of the reaction
mixture was used as the template in a PCR reaction
with the primers ‘LigCbx7-H3K27-forward’ and
‘LigCbx7-H3K27-Backward’.
Purified product from the previous step was digested
with EagI and ligated with similarly digested mCitrine
that had been previously amplified using ‘0-FrWd-EagI
(RF3)-YFP’ and ‘YFP-Primer 4’ primers. The ligation
reaction was allowed to proceed for four hours before
an aliquot was removed and used as the template in a
PCR with the ‘FrWd-KpnI(RF1)-Cbx7’ and ‘YFP-Primer
4’ primers. The product of this PCR reaction was a 3-
part chimera encoding Cbx7-H3K27-mCitrine. This pro-
duct was digested with KpnI and ligated with KpnI-
digested mTFP1 that had been previously amplified
using the ‘TFP-Primer 1’ and ‘0-BkWd-KpnI(RF1)-TFP’
primers. The ligated construct was subsequently sub-
jected to an amplification step using ‘TFP-Primer 1’ and
‘YFP-Primer 4’ primers to produce the full 4-part chi-
mera encoding H3K27-MetBio with the new restriction
sites. This PCR product was digested with XhoI and
HindIII and ligated with the pUADE-vSET plasmid that
had been digested with the same enzymes. This plasmid
was then used for the construction of the linker lengths.
Primers for mTFP1 were designed to incorporate an
XhoI site at the 5’ end and a KpnI site at the 3’ end. For
mTFP1, all deletions or extensions at the C-terminus
are relative to the codon for residue 225 [18]. Primers
for Cbx7 were designed to introduce KpnI and SalI at
the 5’ and 3’ ends respectively. Similarly, primers for
mCitrine introduced an EagI site at the 5’ end and a
stop codon followed by a HindIII site at the 3’ end. PCR
amplifications with each pair of primers were done indi-
vidually, and the resulting PCR products pooled prior to
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digesting and ligation into pUADE. Following ligation, 3
μL of the reaction mixture were used to transform 60
μL of electrocompetent E. coli which were then added
to 3 mL of fresh LB medium containing ampicillin in 10
mL culture tube. After 16 h at 37°C with shaking at 220
rpm, the culture was spun down and plasmid DNA was
extracted. The obtained plasmid DNA was then digested
with EagI and HindIII enzymes to be used in ligation
reaction with mCitrine library. Ligation, transformation
and plasmid DNA preparation proceeded as described
above. Similarly, the KpnI and SalI digested Cbx7 library
was ligated into the pUADE plasmid that contained
mTFP1 and mCitrine libraries.
Western blot procedure
E. coli was transformed with vSET in pBAD/His B and
spread on plates that had been prepared with IPTG (1
mM) and various concentrations L-arabinose (Sigma)
and D-glucose. Colonies were gently scraped off the
plates and B-PER II (Pierce) was used to extract the
soluble proteins from the cell paste according to the
manufacturer’s protocol. Protein concentration was then
determined and 2 μg and 20 μg (in equal volumes) were
subjected to Tricine-SDS-PAGE. Proteins were then
electroblotted on PVDF membrane (Millipore) and tris-
buffered saline pH 7.4 containing 0.1% Tween-20 and
5% non-fat milk was used to block the membrane over-
night at 4°C. The membrane was washed, incubated
with anti-His antibody conjugated with horseradish per-
oxidase (Roche), and rewashed. Locations of the 6 × His
tagged proteins were then detected using ECL chemilu-
minescence substrate (Pierce) and BioMax light film
(Kodak).
Library screening procedure
The library of FRET-based biosensors in pUADE (with
vSET) was used to transform E. coli and transformants
were grown on LB-agar (0.04% ampicillin) in polystyrene
Petri dishes. Sterilized toothpicks were used to stab indi-
vidual colonies and then spot them on two LB-agar
plates at the same relative position. One plate contained
LB/agar supplemented with 0.04% ampicillin, 10 mM L-
arabinose, 10 mM D-glucose and 1 mM IPTG and one
plate contained 0.04% ampicillin, 20 mM D-glucose and
1 mM IPTG. Following overnight incubation at 37°C,
fluorescence images were acquired using custom-made
imaging system that has been previously described [21].
Custom macros were used to process the acquired
images and create a spreadsheet where each row con-
tained a colony identification number along with its
donor and sensitized acceptor emission intensities from
both plates. The spreadsheet was exported to Microsoft
Excel where a Δratio values were calculated for each
colony. Colonies that showed the highest ratio change
were propagated and their plasmid DNA was extracted
and sequenced.
Protein purification
Unless otherwise indicated, pBAD/His B was the expres-
sion plasmid for recombinant protein production, with
nucleotide sequences encoding proteins of interest
inserted between the XhoI and HindIII sites downstream
Para and in-frame with the 5’ 6 × His tag. Over-expres-
sion of the 6 × His-tagged proteins was achieved by L-
arabinose (0.2%) induction of transformed E. coli cul-
tured in 500 mL LB-Lennox media supplemented with
ampicillin (0.04%). The culture was incubated for 22
hours at 37°C with shaking at 240 rpm. Bacterial cells
were collected by centrifugation at 5000 rpm and resus-
pended in 30 mL lysis Buffer (50 mM sodium phosphate,
300 mM sodium chloride, 10 mM imidazole, pH 7.5).
The suspended cells were lysed using French pressure
cell press, debris was pelleted by centrifugation at 14000
rpm, and Ni-NTA resin (Qiagen) were added to the
cleared cell lysate to capture the 6 × His tagged proteins.
Protein purification proceeded according to the proce-
dure provided in the Ni-NTA manual. To minimize pro-
teolytic degradation, Complete Protease inhibitor cocktail
tablets (Roche) were added to all buffers used at the man-
ufacturer’s recommended dose and all steps were per-
formed at 4°C. Proteins were further subjected to gel-
filtration to isolate full-length protein from partially pro-
teolyzed forms on an ÄKTA™-design HPLC using a
HiLoad™ 16/60 Superdex™ 75 pg XK column (GE Life
Sciences). Chromatographic separation was monitored by
absorbance at 280 nm, 462 nm and 513 nm.
In vitro FRET-based assay for vSET activity
The in vitro FRET assay for vSET activity was per-
formed in clear bottom 96-well microplates (Corning).
Each reaction contained 200 μM SAM, 1 μM vSET, 1
μM FRET-based biosensor protein, and 2 mg/mL bovine
serum albumin (BSA) in a buffered solution (50 mM
sodium phosphate, 300 mM sodium chloride, pH 8.0).
Excitation wavelength was set to 420 nm and fluores-
cence emission was collected at 494 nm and 526 nm.
Measurements were collected every 2 minutes for 6 h
using a microplate reader. The ratio of fluorescence
intensity at 526 nm to that at 494 nm was calculated at
each time point. Ratios calculated for control wells that
lacked SAM were averaged and these values were used
as the baseline ratios (Rmin) for each biosensor con-
struct. Changes in FRET were calculated as ΔR/R min
(%) and were plotted against time.
Mammalian cell imaging of H3K27-MetBio3 fused to H2B
To construct a mammalian expression vector encoding a
fusion of H2B and H3K27-MetBio3, the H2B gene was
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PCR amplified with primers H2B-Xho1-F and H2B-
Bgl2-FP-R and the M3K27-MetBio3 gene was PCR
amplified with primers H2B-Bgl2-FP-F and pBAD-R.
Both the H2B (5’ XhoI and 3’ BglII) and H3K27-Met-
Bio3 (5’ BglII and 3’ HindIII) PCR products were sub-
jected to restriction digest followed by purification and
sequential ligations with a modified pcDNA3.1(-) vector.
Mouse embryonic fibroblast (3T3) cells were cultured in
DMEM (Sigma) supplemented with 10% Fetal Bovine
Serum (FBS) (Sigma) at 37°C. Cells in 35 mm imaging
dishes were incubated with 1 ml Dulbecco’s Modified
Eagle Medium (DMEM) (FBS free) for 30 min and then
transfected with 1 μg plasmid DNA that had been
mixed with 2 μl Turbofect™ Protein Transfection
Reagent (Fermentas) in 0.1 ml DMEM (FBS free). The
culture media was changed back to DMEM with 10%
FBS after 2.5 h incubation at 37°C. Images were
acquired 24-48 h post-transfection with cells at room
temperature in HEPES buffered Hanks’ Balanced Salt
Solution (HHBSS) with 25 mM HEPES, 2 g/L D-glucose,
490 μM MgCl2 and 450 μM MgSO4, containing no phe-
nol red.
Imaging was carried on an inverted Nikon Eclipse Ti
microscope equipped with a 75 W xenon lamp
(OSRAM) with a 25% neutral density filter, a 60 ×
objective (NA = 1.4 oil), and a 16-bit 512SC QuantEM
CCD (Photometrics). The NIS-Elements AR 3.2 software
package (Nikon) was used for automated computer con-
trol and for quantitative image analysis. The filters used
for the donor channel were: 455/10 nm excitation; 470
nm dichroic; and 495/30 nm emission. For the FRET
channel the filters were: 455/10 nm excitation; 495 nm
dichroic; and 545/30 nm emission. Ratio images were
created by dividing the FRET image by the donor image,
applying a pseudocolor look-up-table, and scaling each
pixel intensity in the ratio image by the corresponding
pixel intensity for the average of the donor and FRET
channels.
Additional material
Additional file 1: Engineering of double tudor domain and
chromodomain variants with altered binding specificities. A detailed
description of a research effort that involved using phage display-based
screening for the development of improved reagents for molecular
recognition of trimethylated H3K27. This work led to the engineering of
3 protein domains (JMJD2A double tudor domain with D945K; JMJD2A
double tudor domain with the D945R; and Cbx7 chromodomain with
A71K) that were used in the creation of lib1.
Additional file 2: Table S1 Synthetic oligonucleotide sequences.
Synthetic oligonucleotide sequences used in this study.
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